Dulaglutide, a long-acting GLP-1 receptor agonist, can suppress copeptin levels in individuals with euvolaemia, a secondary ...

An initial 6-week course of intranasal saline resolved symptoms for 29.5% of 3- to 12-year-olds with obstructive ...